SCHEMBL24569520

SCHEMBL24569520

Cc1cc(N)ccc1Oc1ccc2c(c1)ncn2C(=O)OC(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MAPT P10636 1/20 0.37
FGFR1 P11362 1/20 0.37
ERBB2 P04626 8/20 0.36
EGFR P00533 6/20 0.36
NR1H2 P55055 1/20 0.35
GAA P10253 2/20 0.34
KMT2A Q03164 2/20 0.34
HPGD P15428 2/20 0.34
BRD4 O60885 2/20 0.34
TNK2 Q07912 1/20 0.33
TSHR P16473 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
USP2 O75604 1/20 0.33
RECQL P46063 1/20 0.33
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
PIK3CD O00329 1/20 0.32
ABL1 P00519 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29888720 1.00 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2MAPTFGFR1ERBB2
SCHEMBL482648 0.84 NR1H2 (0.43) ALDH1A1SMN1; SMN2MAPTFGFR1EGFR
SCHEMBL29887828 0.84 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2MAPTGAAKMT2A
SCHEMBL24569905 0.84 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2MAPTGAAKMT2A
SCHEMBL29888013 0.79 ERBB2 (0.47) ERBB2EGFR
SCHEMBL24569523 0.79 ERBB2 (0.47) ERBB2EGFR
SCHEMBL30137763 0.79 KDR (0.36) EGFRNR1H2BRD4TNK2HSP90AA1
SCHEMBL22076838 0.79 KDR (0.36) EGFRNR1H2BRD4TNK2HSP90AA1
SCHEMBL22076848 0.78 FGFR1 (0.39) ALDH1A1SMN1; SMN2MAPTFGFR1ERBB2
SCHEMBL1191996 0.77 KMT2A (0.46) ALDH1A1SMN1; SMN2MAPTFGFR1ERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022140769-A1 LACTAM (HETERO)ARYLFUSEDPYRIMIDINE DERIVATIVES AS INHIBITORS OF ERBB2 ENLIVEN THERAPEUTICS, INC. (US) 2022-06-30 WO disclosed